Cancer Therapy : Preclinical cSrc Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met
暂无分享,去创建一个
J. Siegfried | J. Grandis | M. Thomas | Cassandra Henry | L. Stabile | V. W. Lui | S. Joyce | G. He | K. Quesnelle | Su | C. Gubish | Kelly M. Quesnelle